FEC Followed by Pertuzumab/Trastuzumab/Docetaxel Regimen

Preferred Label : FEC Followed by Pertuzumab/Trastuzumab/Docetaxel Regimen;

NCIt synonyms : Fluorouracil/Epirubicin/Cyclophosphamide Followed by Pertuzumab/Trastuzumab/Docetaxel; FEC Followed by Docetaxel/Trastuzumab/Pertuzumab; Fluorouracil/Epirubicin/Cyclophosphamide Followed by Pertuzumab Trastuzumab Docetaxel; FEC Followed by Pertuzumab Trastuzumab Docetaxel;

NCIt related terms : FEC-THP (Docetaxel) (trastuzumab-zerc); FEC-THP (Docetaxel); FEC-THP (Docetaxel) (trastuzumab-dkst); FEC-THP (Docetaxel) (trastuzumab-anns); FEC-THP (Docetaxel) (trastuzumab-qyyp); FEC-THP (Docetaxel) (trastuzumab-pkrb); FEC-THP (Docetaxel) (trastuzumab-herw); FEC-THP (Docetaxel) (trastuzumab-dttb);

NCIt definition : A regimen consisting of fluorouracil, epirubicin and intravenous cyclophosphamide, followed by pertuzumab, trastuzumab and docetaxel, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL525014;

Codes from synonyms : 129407; 64059; 129116; 129019; 128922; 128825; 129310; 129213;

Details

Origin ID

C138038;

UMLS CUI

C4527345;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Doxorubicin [NCIt concept]
- Epirubicin Hydrochloride [NCIt concept]
- Fluorouracil [NCIt concept]
- Pertuzumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients